Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human CSNK1A1 Stable Cell Line

    [CAT#: S01YF-1123-KX195]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:
    Kinase Cell Lines

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Based on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.

    Sub Cat Product Name Target Protein Species Host Cell Type Assay Types Inquiry Datasheet
    S01YF-1122-KX1082 Magic™ Human CK1α(CSNK1A1) in Vitro Assay Human Kinase Assay

    Product Information

    Target Protein
    CSNK1A1
    Target Family
    Kinases/Enzyme Drug Discovery Assays and Products
    Target Protein Species
    Human
    Host Cell Type
    CHO-K1; HEK293
    Target Classification
    Kinase Cell Lines
    Target Research Area
    Digestive and Renal Research
    Related Diseases
    Enterobiasis and Amelogenesis Imperfecta, Type Iiia. Among its related pathways are CTNNB1 S45 mutants aren't phosphorylated and Regulation of activated PAK-2p34 by proteasome mediated degradation.
    Gene ID
    UniProt ID

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    A member of the highly conserved serine/threonine protein kinase family is casein kinase 1, alpha 1 (CSNK1A1). There is expression of Csnk1a1 mRNA and protein in various mouse organs, including the ovary. Csnk1a1 mRNA and protein were found in preimplantation embryos following ovulation and fertilization, with two-cell stage embryos exhibiting the highest expression of both molecules. Preimplantation embryos' cytoplasm was likewise where the majority of the CSNK1A1 protein was found. Furthermore, the rate of blastocyst development was significantly reduced in zygotes upon Csnk1a1 knockdown. Moreover, embryonic developmental arrest was also induced by treating zygotes with the CSNK1A1-specific inhibitor D4476. These findings offer the first proof of CSNK1A1's unique role in the early stages of mouse embryonic development. The customized CSNK1A1 stable cell line can be used in antibody discovery and development, potential drug candidate screening and signaling pathway researches.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    chat Kimberly

    The CSNK1A1 KD cell line is easy to use and has become an essential tool in my lab. Dec 06 2020

    chat Verified Customer

    chat Gary

    The CSNK1A1 KD cell line allowed me to perform rigorous experiments with consistent results. Jun 26 2022

    chat Verified Customer

    FAQ

    Any questions about our products? Please visit our frequently asked questions page.

    Published Data

    Fig.1 CK1α mRNA and protein expression in MM patients and cell lines.

    129 MM patients' (pts') PCs (left panel), 36 PCL patients' PCs (middle panel), and 18 MM cell lines' PCs (right panel) CSNK1A1 mRNA expression levels were compared to those of four healthy control PCs.

    Ref: Manni, Sabrina, et al. "Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways." Oncotarget 8.9 (2017): 14604.

    Pubmed: 28099937

    DOI: 10.18632/oncotarget.14654

    Research Highlights

    The CSNK1A1-specific inhibitor D4476 also caused embryonic developmental arrest in zygotes treated with it. These findings offer the first proof of CSNK1A1's unique role in the early stages of mouse embryonic development.
    Ma, Zengyou, et al. "Knockdown of Csnk1a1 results in preimplantation developmental arrest in mice." Theriogenology 198 (2023): 30-35.
    Pubmed: 36542875   DOI: 10.1016/j.theriogenology.2022.12.018

    These findings imply that inhibiting inflammatory factors through targeting Csnk1a1 has an anti-tumor effect, offering a novel approach to the treatment of gliomas.
    Liu, Guanzheng, et al. "Csnk1a1 inhibition modulates the inflammatory secretome and enhances response to radiotherapy in glioma." Journal of Cellular and Molecular Medicine 25.15 (2021): 7395-7406.
    Pubmed: 34216174   DOI: 10.1111/jcmm.16767

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare